The UK's drug safety regulator is asking doctors to be alert for patients who may be misusing obesity injections, such as ...

UK's Medicines and Healthcare products Regulatory Agency (MHRA) approved Eli Lilly's treatment for early Alzheimer's disease, ...

The UK medicines regulator has asked doctors to look out for “signs of misuse” of weight loss drugs among their patients. It ...

The UK’s National Institute of Health and Care Excellence (NICE) said the drug provided only a small benefit to patients.

UK MHRA grants marketing approval to Lilly's Kisunla to treat mild cognitive impairment and mild dementia due to Alzheimer's disease: Indianapolis Thursday, October 24, 2024, 09:0 ...

An Imperial expert in the use artificial intelligence in healthcare has been appointed to the German Ethics Council. Aldo Faisal, Professor of AI and Neuroscience at Imperial College London and ...

Eli Lilly's donanemab receives UK approval for mild cognitive impairment and mild dementia due to Alzheimer's disease.

From new feedback opportunities to shape the future of the National Health Service in England, to multiple changes and ...

Patient Peter Almond told of his disappointment that donanemab will only be available to those who can pay for a private ...

BOSTON and LONDON, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) and Axovia Therapeutics Ltd. today announced a joint research collaboration designed to advance the ...

Global drug shortages underscore the pharmaceutical industry's reliance on fragile supply chains, highlighting the urgent ...